Literature DB >> 25187051

Prevalence of reported peyote use 1985-2010 effects of the American Indian Religious Freedom Act of 1994.

Bob Prue1.   

Abstract

BACKGROUND: Peyote was classified as a hallucinogen in the Drug Abuse Control Act of 1965, leaving American Indian (AI) religious use in legal ambiguity. In 1994, the American Indian Religious Freedom Act was amended to unambiguously protect the right of religious use of peyote for AIs.
OBJECTIVES: The purpose of this article is to report the prevalence rates of peyote use by AIs compared to the rest of the US population and to determine what effect the act's passage had on peyote use rates.
METHODS: This investigation utilized an analysis of existing archived large nationally representative surveys of the American population. Data on peyote use rates was determined for most years 1985 through 2010. A total of 886,088 completed surveys were analyzed, of which 12,749 were from AIs. Use rates were triangulated using peyote harvest data. RESULTS AND
CONCLUSIONS: Peyote use for AIs and the rest of the US population has remained stable between 1% and 2%. American Indian use rose dramatically in the 4 years following the AIRFA and leveled to just under 10%. The rapidity of the rise was excessive in light of the growth in the NAC and compared to the amounts of peyote stocks available. It is hypothesized that social desirability biases suppressed the Pre-AIRFA use rates due to peyote illegal status. SCIENTIFIC SIGNIFICANCE: Beyond describing peyote use rates and the effects of the AIRFA, this research adds to the body of evidence regarding the levels of under-reporting of illicit drugs.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 25187051     DOI: 10.1111/j.1521-0391.2013.12083.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  5 in total

Review 1.  Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico.

Authors:  Snehal R Bhatt; Maya Armstrong; Tassy Parker; Marcello Maviglia; Rebecca Kass; Lawrence Leeman; Paul Romo; Douglas Ziedonis
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

2.  Examination of Recreational and Spiritual Peyote Use Among American Indian Youth.

Authors:  Mark A Prince; Maeve B O'Donnell; Linda R Stanley; Randall C Swaim
Journal:  J Stud Alcohol Drugs       Date:  2019-05       Impact factor: 2.582

3.  Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.

Authors:  Roland R Griffiths; Ethan S Hurwitz; Alan K Davis; Matthew W Johnson; Robert Jesse
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

4.  Impact evaluations of drug decriminalisation and legal regulation on drug use, health and social harms: a systematic review.

Authors:  Ayden I Scheim; Nazlee Maghsoudi; Zack Marshall; Siobhan Churchill; Carolyn Ziegler; Dan Werb
Journal:  BMJ Open       Date:  2020-09-21       Impact factor: 2.692

5.  The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Authors:  Malin Vedøy Uthaug; Alan K Davis; Trevor Forrest Haas; Dawn Davis; Sean B Dolan; Rafael Lancelotta; Christopher Timmermann; Johannes G Ramaekers
Journal:  J Psychopharmacol       Date:  2021-05-05       Impact factor: 4.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.